Skip to main content
PatentCliff

Verzenio Patent Protection

1 patents · Eli Lilly and Company

Reviewed by PatentCliff Editorial Team · Updated
C
Patent Strength
58/100
1
Total Patents
1
Assignees
2031
Earliest Expiration
2031
Latest Expiration

Patent Details

Patent #TitleAssigneeExpiresStatus
7855211Drug substance & product patentEli Lilly and CompanySep 28, 20315.3y left

For Verzenio, the underlying data on this page comes from the FDA Orange Book and USPTO patent records. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.

Every number on this page links back to the FDA Orange Book and USPTO patent records; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for Verzenio is typically a peer within U.S. brand-name drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.